行情

OGEN

OGEN

ORAGENICS
AMEX

实时行情|Nasdaq Last Sale

0.5610
-0.0095
-1.67%
交易中 11:48 04/02 EDT
开盘
0.5600
昨收
0.5705
最高
0.5750
最低
0.5580
成交量
17.43万
成交额
--
52周最高
0.8790
52周最低
0.3500
市值
2,587.60万
市盈率(TTM)
-1.4992
分时
5日
1月
3月
1年
5年

分析师评级

2位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测OGEN价格均价为2.250,最高价位2.500,最低价为2.000。

EPS

OGEN 新闻

更多
  • OGEN: Results from Phase 2 Trial of AG013 in Early 2Q20
  • Zacks Small Cap Research · 03/09 15:50
  • 沪指重返3100点 在岸人民币对美元升破6.90关口
  • 新浪财经 · 01/13 09:30
  • 港股异动 | 小米股价继续反弹,一度大涨超3.5%再创新高
  • 华盛通 · 01/13 06:02
  • 他控告只想再回腾讯上班
  • 创事记 · 01/13 05:47

所属板块

生物技术和医学研究
+2.25%
制药与医学研究
+1.43%

热门股票

代码
价格
涨跌幅

OGEN 简况

Oragenics, Inc. develops, markets and sells probiotics specifically designed to enhance oral health for humans and pets, under the brand names Evora and ProBiora. The Company is focused on offering antibiotics against infectious disease and on developing treatments for oral mucositis. It is engaged in developing its antibiotic product candidate, MU1140, as well as other homolog antibiotic product candidates; researching AG013 in connection with the treatment of Oral Mucositis; commercializing its ProBiora3 probiotic products, and has other product candidates for out licensing or partnering. MU1140 is an antibiotic that is produced by the parent of the SMaRT strain. ProBiora3 is a blend of three naturally occurring strains of beneficial bacteria, including Streptococcus oralis KJ3, Streptococcus uberis KJ2 and Streptococcus rattus JH145. LPT3-04 is a compound, which is consumed in the human diet in small amounts and results in dose-dependent weight loss in experimental animal models.
展开

微牛提供Oragenics Inc(AMEX-OGEN)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的OGEN股票新闻,以帮助您做出投资决策。